Stock Price Quote

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE100.650.15 (+0.15 %)
PREV CLOSE ( ) 100.50
OPEN PRICE ( ) 101.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 179
TODAY'S LOW / HIGH ( )97.10 101.00
52 WK LOW / HIGH ( )60.25 122.8
NSE101.650.4 (+0.4 %)
PREV CLOSE( ) 101.25
OPEN PRICE ( ) 101.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6073
TODAY'S LOW / HIGH( ) 95.45 101.90
52 WK LOW / HIGH ( )61.95 119.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1991
Management Info
R T Ravi - Chairman Avinash Ravi - Managing Director
Registered Office

Address Kothapalli Village,Anakapalli,Kasimkota Mandal,
Vishakhapatnam,
Andhra Pradesh-531031

Phone

Email marketing@krebsbiochem.com / investors@krebsbiochem.com

Website www.krebsbiochem.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

01Feb Allotment of Equity Shares
inter alia, to consider allotment of the following equity shares, warran..
30Dec Allotment of Equity Shares
Preferential Issue of shares & Issue Of Warrants inter alia, 1. Supersed..
22Nov Outcome Of The Extra Ordinary General
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
22Nov Outcome Of The Extra Ordinary General
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
22Nov Outcome Of The Extra Ordinary General
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit-72.81-200.12
Gross Profit -72.81 -200.12
Operating Profit -44.31-94.82
Net Sales 75.46477.57

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7114.30 (1.61%)
M.Cap ( in Cr)16384.68
Aarti Drugs (BSE)
peergroup  746.65 (10.10%)
M.Cap ( in Cr)1739.69
Abbott India (BSE)
peergroup  16249.05 (0.35%)
M.Cap ( in Cr)34528.10
Torrent Pharma (BSE)
peergroup  2249.55 (1.80%)
M.Cap ( in Cr)38064.35
Pfizer (BSE)
peergroup  4192.35 (0.89%)
M.Cap ( in Cr)19179.05

Shareholding Pattern

PROMOTERS 64.66%
NON-INSTITUTION 35.32%
FI/BANKS/INSURANCE 0.01%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd. was incorporated in the year 1991. Its today's share price is 100.5. Its current market capitalisation stands at Rs 181.18 Cr. In the latest quarter, company has reported Gross Sales of Rs. 477.58 Cr and Total Income of Rs.480.89 Cr. The company's management includes Satish Khivsara, Tangirala Malati, Raj Kamal Prasad Verma, G V L Prasad, EJ Babu, Manish Jain, Avinash Ravi, R T Ravi.

It is listed on the BSE with a BSE Code of 524518 , NSE with an NSE Symbol of KREBSBIO and ISIN of INE268B01013. It's Registered office is at Kothapalli Village,Anakapalli,Kasimkota MandalVishakhapatnam-531031, Andhra Pradesh. Their Registrars are ACC Ltd. It's auditors are Pavuluri & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X